Delivery Order SPE2DB22D1017-SPE2DB25FG7DH
- Not listed
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a competitively competed delivery order valued at $14,336.86 by the Defense Logistics Agency on July 14, 2025, with an ultimate completion date of July 15, 2025. The order is for Orencia Clickjet 125 mg/mL, a specialty pharmaceutical product, under firm fixed price terms with no set-aside designation. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $18,423.65 by the Defense Logistics Agency on September 8, 2025, for the supply of Orencia ClickJect 125 mg/mL. This is a firm fixed price, non-set-aside contract with an ultimate completion date of September 9, 2025. The delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $3,594.04 by the Defense Logistics Agency on September 3, 2025, with an ultimate completion date of September 4, 2025. The delivery order, issued under a firm fixed price arrangement with no set-aside designation, covers the supply of Orencia ClickJect 125 mg/mL, a pharmaceutical product to be delivered to the Conshohocken, PA location. This award...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a firm fixed-price delivery order valued at approximately $73,927 by the Defense Logistics Agency (DLA) on August 26, 2025, with completion targeted for August 27, 2025. The delivery order, which carries no set-aside designation, is for Orencia Clickject 125 mg/ml, a specialty pharmaceutical product to be performed at the vendor's corporate office location in Conshohocken,...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on September 19, 2025, for the supply of Orencia ClickJect 125 mg/mL, a pharmaceutical product used in the treatment of rheumatoid arthritis and other autoimmune conditions. This firm fixed-price delivery order, valued at $16,118.84, is classified as a non-set-aside contract and represents a competitive award. The order will be fulfilled from AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a $38,478.55 delivery order to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/ml, a rheumatoid arthritis treatment. This competitively awarded, firm fixed-price delivery order was issued on April 21, 2025, with an ultimate completion date of April 22, 2025, and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The contract represents a child delivery order under AmerisourceBergen's larger Indefinite...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $4,954.49 by the Defense Logistics Agency (DLA) on September 23, 2025, for the supply of Orencia ClickJect 125 mg/mL, a biologic medication used to treat rheumatoid arthritis and other autoimmune conditions. This competitively awarded, firm fixed-price delivery order is set to be completed by September 24, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The award represents...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Orencia 250 mg vials, a pharmaceutical product used in immunological treatment. This firm fixed-price delivery order, valued at $2,141.91, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The contract was...
- AmerisourceBergen Drug Corp, a leading pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order from the Defense Logistics Agency (DLA) for Orencia 125 mg/mL syringes valued at $8,646.31. The award was made on July 31, 2025, with an ultimate completion date of August 1, 2025, under firm fixed pricing with no set-aside designation. This delivery order represents a competitively awarded transaction processed through the company's existing Indefinite...
- The Defense Logistics Agency awarded a $7,188.08 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Orencia Clickject 125 mg/mL on September 8, 2025, with completion targeted for September 9, 2025. This non-competitive delivery order will be fulfilled at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a child contract executed under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) relationship with DLA Troop Support...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB25FG7DHDelivery Order
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $11,601.12 by the Defense Logistics Agency on July 11, 2025, for the supply of Orencia ClickJect 125 mg/ml, a pharmaceutical product used in immunological and rheumatologic treatments. The contract is structured as a firm fixed price delivery order with an ultimate completion date of July 14, 2025, and was awarded through open competition without set-aside designation. This award is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The DLA, operating under the Department of Defense, utilizes its Troop Support Medical supply chain to procure critical pharmaceutical products and medical supplies for military healthcare systems worldwide. AmerisourceBergen's comprehensive pharmaceutical distribution capabilities and existing framework under the SPE2DX prime IDV enable the company to efficiently fulfill specialized medical procurement requirements across multiple therapeutic domains. The firm fixed pricing structure and rapid completion timeline reflect the expedited nature of this particular delivery order for specialized pharmaceutical support to federal healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.6k | 7/11/25 |